INTEKRIN
InteKrin Therapeutics is a clinical-stage, privately held BioPharma company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders. Diseases such as diabetes, metabolic syndrome, and cancer are increasingly in need of novel treatments that provide patients with better treatment alternatives and help to curb soaring healthcare costs. The company is in the process of in-licensing early- and late-stage compounds that have the potential to unlock the complex hormonal relationship between metabolism, insulin resistance, and obesity.
INTEKRIN
Industry:
Biotechnology Neuroscience Therapeutics
Founded:
2005-01-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.intekrin.com
Total Employee:
1+
Status:
Closed
Contact:
650-941-5501
Email Addresses:
[email protected]
Total Funding:
66.42 M USD
Technology used in webpage:
GoDaddy DNS GoDaddy Intermedia
Current Advisors List
Investors List
Asset Management Company
Asset Management Company investment in Venture Round - InteKrin
Asset Management Company
Asset Management Company investment in Venture Round - InteKrin
Asset Management Company
Asset Management Company investment in Series C - InteKrin
Amgen Ventures
Amgen Ventures investment in Series C - InteKrin
Vivo Capital
Vivo Capital investment in Series C - InteKrin
Skyline Ventures
Skyline Ventures investment in Series C - InteKrin
OrbiMed
OrbiMed investment in Series C - InteKrin
Asset Management Ventures (AMV)
Asset Management Ventures (AMV) investment in Series C - InteKrin
Sofinnova Investments
Sofinnova Investments investment in Series C - InteKrin
Sears Capital Management
Sears Capital Management investment in Series C - InteKrin
Official Site Inspections
http://www.intekrin.com
- Host name: 142.215.74.97.host.secureserver.net
- IP address: 97.74.215.142
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "InteKrin"
InteKrin - Crunchbase Company Profile & Funding
InteKrin Therapeutics is a clinical-stage, privately held BioPharma company focused on developing and commercializing breakthrough therapeutics for …See details»
InteKrin Company Profile 2024: Valuation, Investors, Acquisition ...
InteKrin was founded in 2005. Who is the founder of InteKrin? Christos Mantzoros Ph.D and Dennis Lanfear are the founders of InteKrin. Where is InteKrin headquartered? InteKrin is …See details»
INTEKRIN THERAPEUTICS INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for INTEKRIN THERAPEUTICS INC. of Los Altos, CA. Get the latest business insights from Dun & Bradstreet.See details»
InteKrin Therapeutics - Company Profile - Tracxn
InteKrin Therapeutics is a biopharmaceutical company that develops therapeutics for diabetes, obesity and metabolic disorders. The company's lead product, INT131, is a peroxisome …See details»
InteKrin Therapeutics CEO, Founder, Key Executive Team, Board of ...
Explore {InteKrin Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
InteKrin Therapeutics Inc - Company Profile and News
Company profile page for InteKrin Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
InteKrin company information, funding & investors | EIT Health …
InteKrin, welcome to intekrin therapeutics, inc.. Here you'll find information about their funding, investors and team.See details»
InteKrin Therapeutics, Inc.:Company Profile & Technical Research ...
InteKrin Therapeutics, Inc. is a company that provides Insulin, Immune disorder, Medicine and more. InteKrin Therapeutics, Inc. is headquartered in United States California. InteKrin …See details»
InteKrin | EquityNet
InteKrin Therapeutics is a clinical-stage, privately held BioPharma company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and …See details»
Dennis M. Lanfear, Dir. CEO, Pres., InteKrin Therapeutics Inc.
Dir. CEO, Pres. - InteKrin Therapeutics Inc. Dennis Lanfear Email : Please login : Company Name : InteKrin Therapeutics Inc. Company Website : www.intekrin.com : Company Address : 4300 …See details»
InteKrin - Contacts, Employees, Board Members, Advisors & Alumni
InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders.See details»
Intekrin Therapeutics Inc in Los Altos, California - EIN TaxId
The Employer Identification Number (EIN) for Intekrin Therapeutics Inc is 20-3631087. EIN numbers are also referred to as FEIN or FTIN. Find EIN, Contact Details for Intekrin …See details»
InteKrin Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Last update 08 May 2025. InteKrin Therapeutics, Inc. Subsidiary Company | 2005 | California, United States |See details»
InteKrin Therapeutics Inc Company Profile, Financial and
InteKrin Therapeutics Inc., a biopharmaceutical company, develops and commercializes therapeutics for inflammatory and metabolic disorders. The company offers INT131, a …See details»
InteKrin Therapeutics, Inc. - Crunchbase Company Profile & Funding
Who are InteKrin Therapeutics, Inc. 's competitors? Alternatives and possible competitors to InteKrin Therapeutics, Inc. may include Symphony Allegro , Bestukpharma.com , and Tissue …See details»
InteKrin - Tech Stack, Apps, Patents & Trademarks - Crunchbase
InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders. New. Resources. Advanced Search. Start …See details»
InteKrin - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Debt Financing - InteKrin . 2: …See details»
Coherus Biosciences acquires InteKrin - 2014-02-12 - Crunchbase
Feb 12, 2014 InteKrin InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders. Acquiring Organization: …See details»
Organization, dynamics and mechanoregulation of integrin
Sep 27, 2022 Here we review how the interplay of mechanical forces, biochemical signalling and molecular self-organization determines the composition, organization, mechanosensitivity and …See details»
Integrin adhesion complexes: Current Biology - Cell Press
May 24, 2021 In this Primer, Ivaska and colleagues introduce some of the fundamental processes behind the regulation and function of integrin adhesion complexes, including the …See details»